Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avail Dermatology was a Georgia-based dermatology practice group providing general, surgical, cosmetic, and skin cancer dermatology services through multiple outpatient clinic locations in the southern Atlanta region. Originally founded in 1990 and formerly known as Newnan Dermatology, the company expanded to locations including Newnan, Peachtree City, Stockbridge, Carrollton, and Fayetteville. The practice was led by dermatologists including Mark Ling, MD, PhD and Steven Marcet, MD, and offered routine skin care, procedural dermatology, Mohs-related skin cancer care, and cosmetic services. In October 2021, Avail Dermatology was acquired by Epiphany Dermatology, and the legacy Avail brand appears to have been retired in favor of Epiphany branding. It is therefore best characterized as an acquired regional healthcare services company rather than a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avail Dermatology.